Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ProQuad vs MMR II + Varivax in Children 4-6 Years
NCT00985166Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Aug 2000
- Primary completion
- May 2002
- Modality
- Live Attenuated Vaccines
01
Overview
A Phase 3 trial of varicella virus vaccine live in measles, mumps, rubella, varicella (VZV), sponsored by Merck & Co.. Started Aug 2000; status: completed.
02
Drugs
varicella virus vaccine live
03
Conditions
measlesmumpsrubellavaricella (VZV)
Beyond the preview
Go deeper on NCT00985166.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00985166.